Cited by 31Nail Diseases and TreatmentsDermatology and Skin DiseasesAntifungal resistance and susceptibility

New insights into immunity to skin fungi shape our understanding of health and disease

Open access
Ruchti, Fiorella, LeibundGut‐Landmann, Salomé·2023·Parasite Immunology

Abstract

Fungi represent an integral part of the skin microbiota. Their complex interaction network with the host shapes protective immunity during homeostasis. If host defences are breached, skin‐resident fungi including Malassezia and Candida , and environmental fungi such as dermatophytes can cause cutaneous infections. In addition, fungi are associated with diverse non‐infectious skin disorders. Despite their multiple roles in health and disease, fungi remain elusive and understudied, and the mechanisms underlying the emergence of pathological conditions linked to fungi are largely unclear. The identification of IL‐17 as an important antifungal effector mechanism represents a milestone for understanding homeostatic antifungal immunity. At the same time, host‐adverse, disease‐promoting roles of IL‐17 have been delineated, as in psoriasis. Fungal dysbiosis represents another feature of many pathological skin conditions with an unknown causal link of intra‐ and interkingdom interactions to disease pathogenesis. The emergence of new fungal pathogens such as Candida auris highlights the need for more research into fungal immunology to understand how antifungal responses shape health and diseases. Recent technological advances for genetically manipulating fungi to target immunomodulatory fungal determinants, multi‐omics approaches for studying immune cells in the human skin, and novel experimental models open up a promising future for skin fungal immunity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/pim.12948

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 96

  1. [2]Pasparakis M, Haase I, Nestle FO. Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol. 2014; 14(5): 289‐ 301. 24722477
  2. [3]Belkaid Y, Tamoutounour S. The influence of skin microorganisms on cutaneous immunity. Nat Rev Immunol. 2016; 16(6): 353‐ 366. 27231051
  3. [5]Grice EA, Dawson TL. Host‐microbe interactions: Malassezia and human skin. Curr Opin Microbiol. 2017; 40: 81‐ 87. 29141240
  4. [6]Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012; 4(165): 165rv13. 23253612
  5. [8]Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol. 2014; 14(6): 405‐ 416. 24854590 PMC4332855
  6. [9]Vijaya Chandra SH, Srinivas R, Dawson TL, Common JE. Cutaneous. Front Cell Infect Microbiol. 2020; 10: 614446. 33575223 PMC7870721
  7. [10]Theelen B, Cafarchia C, Gaitanis G, Bassukas ID, Boekhout T, Dawson TL. Malassezia ecology, pathophysiology, and treatment. Med Mycol. 2018; 56(suppl_1): S10‐ S25. 29538738
  8. [11]Guillot J, Bond R. Yeasts in veterinary dermatology: an updated overview. Front Cell Infect Microbiol. 2020; 10: 79. 32181160 PMC7059102
  9. [12]Saheb Kashaf S, Proctor DM, Deming C, et al. Integrating cultivation and metagenomics for a multi‐kingdom view of skin microbiome diversity and functions. Nat Microbiol. 2022; 7(1): 169‐ 179. 34952941 PMC8732310
  10. [13]Nagata R, Nagano H, Ogishima D, Nakamura Y, Hiruma M, Sugita T. Transmission of the major skin microbiota, Malassezia, from mother to neonate. Pediatr Int. 2012; 54(3): 350‐ 355. 22300401
  11. [14]Jo JH, Deming C, Kennedy EA, et al. Diverse human skin fungal communities in children converge in adulthood. J Invest Dermatol. 2016; 136(12): 2356‐ 2363. 27476723 PMC5687974
  12. [15]Oh J, Byrd AL, Deming C, et al. Biogeography and individuality shape function in the human skin metagenome. Nature. 2014; 514(7520): 59‐ 64. 25279917 PMC4185404
  13. [16]Hort W, Mayser P. Malassezia virulence determinants. Curr Opin Infect Dis. 2011; 24(2): 100‐ 105. 21192258
  14. [17]Mercer DK, Stewart CS. Keratin hydrolysis by dermatophytes. Med Mycol. 2019; 57(1): 13‐ 22. 29361043
  15. [19]Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008; 51(Suppl 4): S2‐ S15. 18783559
  16. [20]de Hoog GS, Dukik K, Monod M, et al. Toward a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycopathologia. 2017; 182(1–2): 5‐ 31. 27783317 PMC5283515
  17. [21]Seyedmousavi S, Bosco SMG, de Hoog S, et al. Fungal infections in animals: a patchwork of different situations. Med Mycol. 2018; 56(suppl_1): S165‐ S187. PMC6251577 29538732
  18. [22]Huppler AR, Bishu S, Gaffen SL. Mucocutaneous candidiasis: the IL‐17 pathway and implications for targeted immunotherapy. Arthritis Res Ther. 2012; 14(4): 217. 22838497 PMC3580547
  19. [23]Struck MF, Gille J. Fungal infections in burns: a comprehensive review. Ann Burns Fire Disasters. 2013; 26(3): 147‐ 153. 24563641 PMC3917146
  20. [24]Becker WK, Cioffi WG, McManus AT, et al. Fungal burn wound infection. A 10‐year experience. Arch Surg. 1991; 126(1): 44‐ 48. 1985634
  21. [25]Kalan L, Loesche M, Hodkinson BP, et al. Redefining the chronic‐wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. mBio. 2016; 7(5): e01058‐16. 27601572 PMC5013295
  22. [26]Borman AM, Fraser M, Patterson Z, Linton CJ, Palmer M, Johnson EM. Fungal infections of implantation: more than five years of cases of subcutaneous fungal infections seen at the UK Mycology Reference Laboratory. J Fungi. 2022; 8(4): 343. PMC9028115 35448574
  23. [27]Bonifaz A, Vázquez‐González D, Perusquía‐Ortiz AM. Subcutaneous mycoses: chromoblastomycosis, sporotrichosis and mycetoma. J Dtsch Dermatol Ges. 2010; 8(8): 619‐ 627. quiz 628. 20529168
  24. [28]DeAngelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson TL. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc. 2005; 10(3): 295‐ 297. 16382685
  25. [29]Kashem SW, Kaplan DH. Skin immunity to Candida albicans. Trends Immunol. 2016; 37(7): 440‐ 450. 27178391 PMC4931795
  26. [30]Igyártó BZ, Haley K, Ortner D, et al. Skin‐resident murine dendritic cell subsets promote distinct and opposing antigen‐specific T helper cell responses. Immunity. 2011; 35(2): 260‐ 272. 21782478 PMC3163010
  27. [31]Iliev ID, Leonardi I. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat Rev Immunol. 2017; 17(10): 635‐ 646. 28604735 PMC5724762
  28. [32]Lionakis MS, Iliev ID, Hohl TM. Immunity against fungi. JCI Insight. 2017; 2(11): e93156. 28570272 PMC5453709
  29. [33]LeibundGut‐Landmann S, Gross O, Robinson MJ, et al. Syk‐ and CARD9‐dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007; 8(6): 630‐ 638. 17450144
  30. [34]Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev. 2009; 227(1): 221‐ 233. 19120487
  31. [35]Alves de Medeiros AK, Lodewick E, Bogaert DJ, et al. Chronic and invasive fungal infections in a family with CARD9 deficiency. J Clin Immunol. 2016; 36(3): 204‐ 209. 26961233
  32. [37]Corvilain E, Casanova JL, Puel A. Inherited CARD9 deficiency: invasive disease caused by ascomycete fungi in previously healthy children and adults. J Clin Immunol. 2018; 38(6): 656‐ 693. 30136218 PMC6157734
  33. [39]Huang X, Hurabielle C, Drummond RA, et al. Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies. Cell Host Microbe. 2021; 29(2): 210‐ 221.e216. 33385336 PMC7878403
  34. [40]Lanternier F, Barbati E, Meinzer U, et al. Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection. J Infect Dis. 2015; 211(8): 1241‐ 1250. 25057046 PMC4447834
  35. [41]Yamasaki S, Matsumoto M, Takeuchi O, et al. C‐type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc Natl Acad Sci U S A. 2009; 106(6): 1897‐ 1902. 19171887 PMC2644135
  36. [42]Ishikawa T, Itoh F, Yoshida S, et al. Identification of distinct ligands for the C‐type lectin receptors Mincle and Dectin‐2 in the pathogenic fungus Malassezia. Cell Host Microbe. 2013; 13(4): 477‐ 488. 23601109
  37. [43]Wolf AJ, Limon JJ, Nguyen C, Prince A, Castro A, Underhill DM. Malassezia spp. induce inflammatory cytokines and activate NLRP3 inflammasomes in phagocytes. J Leukoc Biol. 2021; 109(1): 161‐ 172. 32941658 PMC7902306
  38. [44]Kistowska M, Fenini G, Jankovic D, et al. Malassezia yeasts activate the NLRP3 inflammasome in antigen‐presenting cells via Syk‐kinase signalling. Exp Dermatol. 2014; 23(12): 884‐ 889. 25267545
  39. [46]Baroni A, Orlando M, Donnarumma G, et al. Toll‐like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res. 2006; 297(7): 280‐ 288. 16283346
  40. [47]Moretti S, Bellocchio S, Bonifazi P, et al. The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol. 2008; 1(2): 156‐ 168. 19079173
  41. [48]Applen Clancey S, Ruchti F, LeibundGut‐Landmann S, Heitman J, Ianiri G. A novel mycovirus evokes transcriptional rewiring in the fungus Malassezia and stimulates beta interferon production in macrophages. mBio. 2020; 11(5): e01534‐20. 32873760 PMC7468202
  42. [49]Park M, Cho YJ, Kim D, et al. A novel virus alters gene expression and vacuolar morphology in Malassezia cells and induces a TLR3‐mediated inflammatory immune response. mBio. 2020; 11(5): e01521‐20. 32873759 PMC7468201
  43. [52]Sparber F, LeibundGut‐Landmann S. Interleukin‐17 in antifungal immunity. Pathogens. 2019; 8(2): 54. 31013616 PMC6630750
  44. [53]Becattini S, Latorre D, Mele F, et al. T cell immunity. Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines. Science. 2015; 347(6220): 400‐ 406. 25477212
  45. [54]Park CO, Fu X, Jiang X, et al. Staged development of long‐lived T‐cell receptor αβ T. J Allergy Clin Immunol. 2018; 142(2): 647‐ 662. 29128674 PMC5943196
  46. [56]Burstein VL, Guasconi L, Beccacece I, et al. IL‐17‐mediated immunity controls skin infection and T helper 1 response during experimental Microsporum canis dermatophytosis. J Invest Dermatol. 2018; 138(8): 1744‐ 1753. 29571944
  47. [58]Urban CF, Ermert D, Schmid M, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009; 5(10): e1000639. 19876394 PMC2763347
  48. [60]Roussel L, Houle F, Chan C, et al. IL‐17 promotes p38 MAPK‐dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol. 2010; 184(8): 4531‐ 4537. 20228195
  49. [61]Schönherr FA, Sparber F, Kirchner FR, et al. The intraspecies diversity of C. albicans triggers qualitatively and temporally distinct host responses that determine the balance between commensalism and pathogenicity. Mucosal Immunol. 2017; 10(5): 1335‐ 1350. 28176789
  50. [62]Liu Y, Yang B, Zhou M, et al. Memory IL‐22‐producing CD4+ T cells specific for Candida albicans are present in humans. Eur J Immunol. 2009; 39(6): 1472‐ 1479. 19449309
  51. [64]Ridaura VK, Bouladoux N, Claesen J, et al. Contextual control of skin immunity and inflammation by Corynebacterium. J Exp Med. 2018; 215(3): 785‐ 799. 29382696 PMC5839758
  52. [66]Gladiator A, Wangler N, Trautwein‐Weidner K, LeibundGut‐Landmann S. Cutting edge: IL‐17‐secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol. 2013; 190(2): 521‐ 525. 23255360
  53. [67]Dunne PJ, Maher CO, Freeley M, et al. CD3ε expression defines functionally distinct subsets of Vδ1 T cells in patients with human immunodeficiency virus infection. Front Immunol. 2018; 9: 940. 29770136 PMC5940748
  54. [68]Hurabielle C, Link VM, Bouladoux N, et al. Immunity to commensal skin fungi promotes psoriasiform skin inflammation. Proc Natl Acad Sci U S A. 2020; 117(28): 16465‐ 16474. 32601220 PMC7368261
  55. [69]Naik S, Bouladoux N, Linehan JL, et al. Commensal‐dendritic‐cell interaction specifies a unique protective skin immune signature. Nature. 2015; 520(7545): 104‐ 108. 25539086 PMC4667810
  56. [70]Verma AH, Richardson JP, Zhou C, et al. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Sci Immunol. 2017; 2(17): eaam8834. 29101209 PMC5881387
  57. [71]Kashem SW, Riedl MS, Yao C, Honda CN, Vulchanova L, Kaplan DH. Nociceptive sensory fibers drive Interleukin‐23 production from CD301b+ dermal dendritic cells and drive protective cutaneous immunity. Immunity. 2015; 43(3): 515‐ 526. 26377898 PMC4607048
  58. [72]Cohen JA, Edwards TN, Liu AW, et al. Cutaneous TRPV1. Cell. 2019; 178(4): 919‐ 932.e914. 31353219 PMC6788801
  59. [73]Riol‐Blanco L, Ordovas‐Montanes J, Perro M, et al. Nociceptive sensory neurons drive interleukin‐23‐mediated psoriasiform skin inflammation. Nature. 2014; 510(7503): 157‐ 161. 24759321 PMC4127885
  60. [74]Bacher P, Heinrich F, Stervbo U, et al. Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell. 2016; 167(4): 1067‐ 1078.e1016. 27773482
  61. [75]Acosta‐Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17‐producing T helper memory cells. Nat Immunol. 2007; 8(6): 639‐ 646. 17486092
  62. [76]Lund A, Deboer DJ. Immunoprophylaxis of dermatophytosis in animals. Mycopathologia. 2008; 166(5–6): 407‐ 424. 18478355
  63. [77]Kirchner FR, LeibundGut‐Landmann S. Tissue‐resident memory Th17 cells maintain stable fungal commensalism in the oral mucosa. Mucosal Immunol. 2021; 14(2): 455‐ 467. 32719409 PMC7946631
  64. [78]Hartwig T, Pantelyushin S, Croxford AL, Kulig P, Becher B. Dermal IL‐17‐producing γδ T cells establish long‐lived memory in the skin. Eur J Immunol. 2015; 45(11): 3022‐ 3033. 26332438
  65. [79]Ramírez‐Valle F, Gray EE, Cyster JG. Inflammation induces dermal Vγ4+ γδT17 memory‐like cells that travel to distant skin and accelerate secondary IL‐17‐driven responses. Proc Natl Acad Sci U S A. 2015; 112(26): 8046‐ 8051. 26080440 PMC4491769
  66. [80]Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe. 2011; 9(5): 355‐ 361. 21575907
  67. [81]Sheridan BS, Romagnoli PA, Pham QM, et al. γδ T cells exhibit multifunctional and protective memory in intestinal tissues. Immunity. 2013; 39(1): 184‐ 195. 23890071 PMC3749916
  68. [82]Bartlett HS, Million RP. Targeting the IL‐17‐T(H)17 pathway. Nat Rev Drug Discov. 2015; 14(1): 11‐ 12. 25549584
  69. [83]Schnell A, Huang L, Singer M, et al. Stem‐like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell. 2021; 184(26): 6281‐ 6298.e6223. 34875227 PMC8900676
  70. [84]Shao TY, Ang WXG, Jiang TT, et al. Commensal Candida albicans positively calibrates systemic Th17 immunological responses. Cell Host Microbe. 2019; 25(3): 404‐ 417.e406. 30870622 PMC6419754
  71. [85]Balaji H, Heratizadeh A, Wichmann K, et al. Malassezia sympodialis thioredoxin‐specific T cells are highly cross‐reactive to human thioredoxin in atopic dermatitis. J Allergy Clin Immunol. 2011; 128(1): 92‐ 99.e94. 21489611
  72. [86]Vilhelmsson M, Glaser AG, Martinez DB, et al. Mutational analysis of amino acid residues involved in IgE‐binding to the Malassezia sympodialis allergen Mala s 11. Mol Immunol. 2008; 46(2): 294‐ 303. 18922581
  73. [87]Schmid‐Grendelmeier P, Flückiger S, Disch R, et al. IgE‐mediated and T cell‐mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol. 2005; 115(5): 1068‐ 1075. 15867868
  74. [88]Sugaya M. The role of Th17‐related cytokines in atopic dermatitis. Int J Mol Sci. 2020; 21(4): 1314. 32075269 PMC7072946
  75. [89]Casagrande BF, Flückiger S, Linder MT, et al. Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema. J Invest Dermatol. 2006; 126(11): 2414‐ 2421. 16778796
  76. [90]Krämer HJ, Podobinska M, Bartsch A, et al. Malassezin, a novel agonist of the aryl hydrocarbon receptor from the yeast Malassezia furfur, induces apoptosis in primary human melanocytes. Chembiochem. 2005; 6(5): 860‐ 865. 15812864
  77. [91]Dowd SE, Delton Hanson J, Rees E, et al. Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care. 2011; 20(1): 40‐ 47. 21278640
  78. [92]Poh SE, Goh JPZ, Fan C, et al. Identification of Malassezia furfur secreted aspartyl protease 1 (MfSAP1) and its role in extracellular matrix degradation. Front Cell Infect Microbiol. 2020; 10: 148. 32328468 PMC7161080
  79. [93]Xu J, Saunders CW, Hu P, et al. Dandruff‐associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens. Proc Natl Acad Sci U S A. 2007; 104(47): 18730‐ 18735. 18000048 PMC2141845
  80. [94]Gaitanis G, Magiatis P, Stathopoulou K, et al. AhR ligands, malassezin, and indolo[3,2‐b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis. J Invest Dermatol. 2008; 128(7): 1620‐ 1625. 18219281
  81. [95]Burstein VL, Beccacece I, Guasconi L, Mena CJ, Cervi L, Chiapello LS. Skin immunity to dermatophytes: from experimental infection models to human disease. Front Immunol. 2020; 11: 605644. 33343578 PMC7738607
  82. [97]Gow NAR, Yadav B. Microbe profile: Candida albicans: a shape‐changing, opportunistic pathogenic fungus of humans. Microbiology. 2017; 163(8): 1145‐ 1147. 28809155
  83. [98]Moyes DL, Wilson D, Richardson JP, et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature. 2016; 532(7597): 64‐ 68. 27027296 PMC4851236
  84. [99]Liu J, Willems HME, Sansevere EA, et al. A variant ECE1 allele contributes to reduced pathogenicity of Candida albicans during vulvovaginal candidiasis. PLoS Pathog. 2021; 17(9): e1009884. 34506615 PMC8432879
  85. [100]Alshahni MM, Yamada T. Genetic manipulations in dermatophytes. Mycopathologia. 2017; 182(1–2): 33‐ 43. 27435975
  86. [101]Ianiri G, Heitman J. Approaches for genetic discoveries in the skin commensal and pathogenic. Front Cell Infect Microbiol. 2020; 10: 393. 32850491 PMC7426719
  87. [102]Krüger W, Vielreicher S, Kapitan M, Jacobsen ID, Niemiec MJ. Fungal‐bacterial interactions in health and disease. Pathogens. 2019; 8(2): 70. 31117285 PMC6630686
  88. [103]Tao R, Li R, Wang R. Dysbiosis of skin mycobiome in atopic dermatitis. Mycoses. 2022; 65(3): 285‐ 293. 34817898
  89. [104]Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol. 2018; 26(6): 484‐ 497. 29233606
  90. [105]Kobayashi T, Glatz M, Horiuchi K, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015; 42(4): 756‐ 766. 25902485 PMC4407815
  91. [106]Li H, Goh BN, Teh WK, et al. Skin commensal Malassezia globosa secreted protease attenuates Staphylococcus aureus biofilm formation. J Invest Dermatol. 2018; 138(5): 1137‐ 1145. 29246799
  92. [109]Ianiri G, Coelho MA, Ruchti F, et al. HGT in the human and skin commensal. Proc Natl Acad Sci U S A. 2020; 117(27): 15884‐ 15894. 32576698 PMC7354939
  93. [110]Wu G, Zhao H, Li C, et al. Genus‐wide comparative genomics of Malassezia delineates its phylogeny, physiology, and niche adaptation on human skin. PLoS Genet. 2015; 11(11): e1005614. 26539826 PMC4634964
  94. [111]Li XV, Leonardi I, Putzel GG, et al. Immune regulation by fungal strain diversity in inflammatory bowel disease. Nature. 2022; 603(7902): 672‐ 678. 35296857 PMC9166917
  95. [112]Sparber F, LeibundGut‐Landmann S. Infecting mice with Malassezia spp. to study the fungus‐host interaction. J Vis Exp. 2019;(153). doi: 10.3791/60175 31762452 · DOI
  96. [113]Heinen MP, Cambier L, Antoine N, et al. Th1 and Th17 immune responses act complementarily to optimally control superficial dermatophytosis. J Invest Dermatol. 2019; 139(3): 626‐ 637. 30227138

Cited by

Sorted by citations

Authors
Ruchti, F., & LeibundGut‐Landmann, S.
Affiliations
University of Zurich (CH)
Corresponding author
LeibundGut‐Landmann, Salomé
Venue
Parasite Immunology
Publisher
Wiley
Published
2022-09-20
Volume
45
Issue
2
Pages
e12948-e12948
ISSN
  • 0141-9838 (ISSN-L)
  • 1365-3024
OpenAlex
W4294124689
Cited by
31
References
17
Citations by year
2026: 8 · 2025: 11 · 2024: 6 · 2023: 5 · 2022: 1
FWCI
0.91
Type
journal article
Language
en
Open access
Locations
  • Parasite Immunology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_189255)
Topics
  • Health Sciences › Medicine › Epidemiology › Nail Diseases and Treatments
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
fungal skin infection, Malassezia, Candida, dermatophytes, IL-17, antifungal immunity, fungal dysbiosis, psoriasis, Candida auris, skin microbiome, host-fungus interactions
MeSH terms
Antifungal Agents, Fungi, Humans, Malassezia, Skin, Interleukin-17, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review